Beauren Korea showcased its Miracletox anti-aging at-home beauty treatment at the Cosmobeauty Seoul trade show, which includes an innovative ampoule component.
The Time Rewind Perfection TOX Ampoule takes inspiration from the popularity of microneedling treatments, but in a fresh and non-invasive way. The Miracletox product features a Micro-Spear ingredient, which is derived from hydrolyzed freshwater sponge. As a sponge is nothing more than a mass of cells held together by small needle-shaped bodies of silica, these "needles" are reduced to a micro size and blended into the ampoule formula.
The complete Miracletox product collection from Beauren also includes creams and masks that also make the most of Micro-Spear technology to drive beneficial nutrients deep into the skin and promote a healthy, rejuvenated and youthful-looking complexion.
Deeply Preserving Serums
Beauren's Miracletox Mimics Microneedling with 'Micro-Spear' Technology
Trend Themes
1. Micro-spear Technology - Micro-Spear technology can be adopted in various beauty treatments to drive nutrients deep into the skin without the need for invasive procedures.
2. Non-invasive Anti-aging Treatments - Non-invasive anti-aging treatments that are inspired by popular invasive procedures are becoming more popular in the beauty industry.
3. Ampoule-based Beauty Treatments - Ampoule-based beauty treatments are gaining popularity in the beauty industry as they are designed to deliver effective results in a few steps.
Industry Implications
1. Beauty Industry - Beauty companies can invest in new non-invasive technologies that mimic popular invasive procedures to cater to customers who wish to avoid invasive treatments.
2. Skincare Industry - Skincare companies can benefit by adopting ampoule-based beauty treatments in their product lines as they are gaining popularity among customers.
3. Health and Wellness Industry - The health and wellness industry can benefit by partnering with beauty companies to offer non-invasive anti-aging solutions that cater to the growing demand for such treatments.